Hong-Lei Ma

发表

FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2020, British Journal of Nutrition.

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

M. Zheng, Wen-Yue Liu, J. George, 2020, Metabolism.

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2022, Frontiers in Medicine.

Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2021, Journal of clinical and translational hepatology.

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis

M. Zheng, K. Pan, J. George, 2020, Journal of Hepatology.

Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2020, Journal of gastroenterology and hepatology.

Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease.

M. Zheng, Wen-Yue Liu, Xiao-dong Wang, 2020, European journal of gastroenterology & hepatology.

Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis

M. Zheng, Wen-Yue Liu, Xiao-dong Wang, 2021, Journal of clinical and translational hepatology.

Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis

M. Zheng, Wen-Yue Liu, C. Byrne, 2021, Journal of clinical and translational hepatology.

Associations of 17-beta dehydrogenase 13 variants with liver histology in Chinese patients with MAFLD

M. Zheng, Wen-Yue Liu, M. Eslam, 2021 .

PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease

M. Zheng, C. Byrne, G. Targher, 2021, Journal of clinical and translational hepatology.

Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease

M. Zheng, C. Byrne, G. Targher, 2021, British Journal of Nutrition.

PNPLA3 Polymorphism Influences The Association Between High-Normal Tsh Level And Nash In Euthyroid Adults With Biopsy-Proven Nafld.

M. Zheng, Wen-Yue Liu, G. Targher, 2020, Diabetes & metabolism.

PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels

M. Zheng, Dan-Qin Sun, Xiao-dong Wang, 2020, Liver international : official journal of the International Association for the Study of the Liver.

C>G variant influences the association between 2 visceral fat and significant fibrosis in biopsy-proven NAFLD

M. Zheng, C. Byrne, G. Targher, 2021 .

Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD.

V. Wong, M. Zheng, C. Byrne, 2021, Metabolism: clinical and experimental.

Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease

M. Zheng, Wen-Yue Liu, C. Byrne, 2020, Journal of gastroenterology and hepatology.

Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD

M. Zheng, C. Byrne, Kenneth I. Zheng, 2021, Journal of hepato-biliary-pancreatic sciences.

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Wen-Yue Liu, J. George, Ting-Yao Wang, 2020 .

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

M. Zheng, Jian Wu, Yumin Wang, 2021, Clinical and molecular hepatology.

Metabolic‐associated fatty liver disease is associated with severity of COVID‐19

M. Zheng, J. George, Ting-Yao Wang, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels

M. Zheng, Wen-Yue Liu, C. Byrne, 2020, BMJ Open Diabetes Research & Care.

Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD.

M. Zheng, C. Byrne, G. Targher, 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both.

Dan-Qin Sun, Wen-Yue Liu, A. Lonardo, 2024, Journal of hepatology.

Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case–control study

M. Zheng, G. Targher, C. Byrne, 2022, European journal of gastroenterology & hepatology.

Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis.

M. Zheng, Kenneth I. Zheng, Yong-Ping Chen, 2021, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients

M. Ghanbari, M. Zheng, Wen-Yue Liu, 2021, Clinical and molecular hepatology.

Title: Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients Short title: Klotho rs495392 and NAFLD

M. Ghanbari, M. Zheng, Wen-Yue Liu, 2021 .